Skip to content

Effect of viseral manipulation in constipation

Effect of visceral manipulation on children with chronic functional constipation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190614043891N1
Enrollment
20
Registered
2019-12-04
Start date
2019-12-22
Completion date
Unknown
Last updated
2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation. Functional intestinal disorder, unspecified

Interventions

Intervention 1: Intervention group: In the intervention group, in addition to the standard medical treatments that are given in both groups, visceral manipulation techniques are applied for four weeks

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 18 Years

Inclusion criteria

Inclusion criteria: All children with Functional constipation aged 5 to 18 years At least 3 months have passed since they occurred

Exclusion criteria

Exclusion criteria: Endocrine and Metabolic disorders (eg, Hypothyroidism, Hypercalcemia, Diabetes mellitus) Neurologic and Psychiatric disorders(Spina bifida, Cerebral palsy, Autism) Hirschsprung’sdisease and Down’s syndrome Congenital anorectal malformation

Design outcomes

Primary

MeasureTime frame
Bristol scale score that measure the consistency and shape of the stool. Timepoint: At the beginning of the study (before the intervention) and 28 days after the intervention. Method of measurement: Bristol Stool Form Scale.;Score of defecation pain. Timepoint: At the beginning of the study (before the intervention) and 28 days after the intervention. Method of measurement: Wong-Baker Faces Pain Rating Scale.;Score of abdominal pain. Timepoint: At the beginning of the study (before the intervention) and 28 days after the intervention. Method of measurement: Wong-Baker Faces Pain Rating Scale.;Number of defecation per week. Timepoint: At the beginning of the study (before the intervention) and 28 days after the intervention. Method of measurement: Patient report.

Secondary

MeasureTime frame
Dosage of laxative drug. Timepoint: At the beginning of the study (before the intervention) and 28 days after the intervention. Method of measurement: Patient report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Ravanbakhsh

Ahvaz University of Medical Sciences

majidravanbakhsh@yahoo.com+98 61 3743 1013

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026